Intervention with epinephrine in hypotension associated with mastocytosis

The Journal of Allergy and Clinical Immunology

Volumn 71, Issue 2, 1983, Pages 189-192

  Turk, John ^a   Oates, John A ^a   Roberts II, L Jackson ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHLORPHENIRAMINE; CIMETIDINE; DOPAMINE; METHYLPREDNISOLONE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CASE REPORT; DRUG THERAPY; HEMODYNAMICS; HUMAN; HYPOTENSION; MASTOCYTOSIS; THERAPY; VASODILATATION;

AGED; ANIMAL; CASE REPORT; CREATININE; CYCLIC AMP; DOGS; EPINEPHRINE; FEMALE; GUINEA PIGS; HISTAMINE; HUMAN; HYPOTENSION; MALE; MAST CELLS; PROSTAGLANDINS D; RATS; SUPPORT, U.S. GOV'T, P.H.S.; URTICARIA PIGMENTOSA;

EID: 0020683503     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(83)90098-2     Document Type: Article

References (27)

1. Histamine and mastocytosis
2. The mastocytosis syndrome. Clinical and biological studies
3. Fatal anaphylaxis in systemic mastocytosis
4. Epinephrine in the treatment of mastocytosis (letter)
5. 2 in patients with systemic mastocytosis
6. Oral disodium cromoglycate in the treatment of mastocytosis
7. Systemic mast cell disease in a patient with unusual gastrointestinal and pulmonary abnormalities
8. Urticaria pigmentosa (mastocytosis)
9. The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis
10. Urticaria pigmentosa treatment with cimetidine and chlorpheniramine
11. Modification of the enzymatic isotope assay of histamine and its application to measurement of histamine in tissues, serum, and urine
12. 2 urinary metabolite 9α-hydroxy-11, 15-dioxo-2, 3, 18, 19-tetranorprost-5-ene-1, 20-dioic acid by stable isotope dilution assay
13. 2α in plasma using high performance liquid chromatography and gas chromatography-mass spectrometry
14. 2 in the monkey
15. Aspirin desensitization in aspirin-sensitive asthmatics: characterization of the refractory period
16. Histamine shock
17. On the mechanism of vascular leakage caused by histamine type mediators
18. 2 in the dog
19. 2 production by rat and human mast cells activated by reversed anaphylaxis
20. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks
21. Pheochromocytoma and essential hypertensive vascular disease
22. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man
23. Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man
24. Modulation of cyclic AMP in purified rat mast cells. Response to pharmacologic, metabolic, and physical stimuli
25. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and alpha adrenergic stimulation
26. The effects of immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation
27. Pharmacologic modification of thromboxane and prostaglandin release in cardiac anaphylaxis